Top Markets
Coin of the day
Osteopore Limited Osteopore Limited

Osteopore Limited

OSX
Clasificación en acciones #38623
Established in Singapore in 2003, Osteopore Limited focuses on engineering,... Established in Singapore in 2003, Osteopore Limited focuses on engineering, manufacturing, and globally commercializing bioresorbable polymer implants. These advanced devices are utilized in neurosurgical, orthopedic, and maxillofacial operations throughout Singapore, Australia, and other international regions. The company's core innovation involves employing 3D printing with bioresorbable materials to create custom, micro-structured scaffolds specifically designed to foster bone regeneration. Its product portfolio includes Osteoplug, a resorbable implant for sealing trephination burr holes during neurosurgery, and Osteomesh, another resorbable implant used in craniofacial surgery to mend various fractures, including orbital floor injuries, and to fill surgical voids. Additionally, Osteopore has forged a collaborative partnership with Livingstone Health Holding Limited to jointly pioneer new products and applications for bone and tissue regeneration.
Precio por acción
$0.00282114
Última sincronización: 2026-08-13
Capitalización bursátil
$884.39K
Cambio (1 día)
0.00%
Cambio (1 año)
-51.76%
País
AU
Comercio Osteopore Limited (OSX)

Categoría

Ingresos de Osteopore Limited (OSX)
Ingresos en Aug 2026 TTM: 0
Según los últimos informes financieros de Osteopore Limited, los ingresos actuales de la empresa (TTM) son 0. En 2026, la empresa obtuvo unos ingresos de 0 igual a los ingresos del año 2026, que fueron de 0. Los ingresos representan la cantidad total que una empresa genera por la venta de bienes o servicios. A diferencia de las ganancias, no se restan los gastos.
Historial de ingresos de Osteopore Limited desde 2026 hasta 2026
Ingresos al final de cada año
Año Ingresos Cambiar
Not enough data for the provided dates.
Ingresos de empresas similares o competidoras
Empresa Ingresos Diferencia de ingresos País
$11.03B -
US
$34.74B -
FR
- -
JP
$20.84B -
US
- -
CH